India's largest public research network, bringing water purification, vaccine delivery, and field-testing capacity to EU-India collaborative projects.
CSIR is India's largest publicly funded R&D organization, operating a network of 38 national laboratories across diverse scientific disciplines. In European collaborations, they bring deep expertise in water treatment technologies — including bio-mimetic desalination, low-cost purification systems, and water quality monitoring for rural and peri-urban communities. They also contribute to global health through next-generation influenza vaccine development, including needle-free delivery systems and microneedle patches. Their role in H2020 is consistently as an international knowledge partner, providing testing grounds and scientific capacity from the Indian research ecosystem.
Core contributor to INDIA-H2O (bio-mimetic desalination, forward/reverse osmosis), PAVITR (natural wastewater treatment), LOTUS (water quality monitoring), and PANI WATER (photo-irradiation water treatment).
LOTUS focused on low-cost sensors, decision support systems, and monitoring for water distribution and irrigation; PAVITR on high-resolution water management.
INDIGO and ENDFLU projects cover next-generation influenza vaccines including needle-free intradermal patches, microneedle delivery, and recombinant protein-based constructs through Phase 1 clinical trials.
RE-EMPOWERED project on multi-energy carrier integration and energy islands for Indian and European communities.
CSIR's H2020 engagement began in 2019 concentrated entirely on water — desalination membranes, osmosis technologies, and wastewater treatment for developing-world contexts. From 2020 onward, they diversified into global health (influenza vaccine platforms with needle-free delivery) and renewable energy microgrids. This shift suggests CSIR is broadening its EU collaboration footprint beyond environmental engineering into health and energy, likely reflecting India-EU strategic research priorities.
CSIR is expanding from its water technology base into health technologies and decentralized energy, positioning itself as a multi-domain international research partner for EU-India collaborative calls.
CSIR never coordinates H2020 projects — it joins as an international partner or participant, which is typical for non-EU research organizations in Horizon 2020. With 127 unique consortium partners across 18 countries, they operate in large, multi-national consortia rather than small focused teams. Their consistent presence across multiple water-sector projects suggests they are a trusted go-to partner for EU consortia needing Indian research infrastructure and field-testing capacity.
CSIR has collaborated with 127 distinct partners across 18 countries, reflecting broad geographic reach typical of large EU-India cooperative research projects. Their network spans European research institutions and extends into applied field-testing partnerships in the Indian subcontinent.
CSIR brings something most European partners cannot: access to India's vast research laboratory network (38 labs, 4,600+ scientists) and real-world testing environments for technologies targeting developing-world conditions. For water treatment and vaccine delivery projects, this means field validation at scale in communities that actually face the problems being solved. Any consortium targeting EU-India collaborative calls or needing deployment testing in tropical, resource-constrained settings should consider CSIR a strategic partner.
